Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/2012
01/26/2012US20120020986 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa
01/26/2012US20120020985 Antibodies against il-17br
01/26/2012US20120020983 Emp2 antibodies and their therapeutic uses
01/26/2012US20120020981 Anti-IL6/IL-6R Antibodies and Methods of Use Thereof
01/26/2012US20120020980 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
01/26/2012US20120020978 Antibodies against fatty acid synthase
01/26/2012US20120020977 Pancreatic cancer genes
01/26/2012US20120020976 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
01/26/2012US20120020973 Chimeric ospa genes, proteins, and methods of use thereof
01/26/2012US20120020972 Antibodies relating to pivka-ii and uses thereof
01/26/2012US20120020971 Antibodies useful in passive influenza immunization
01/26/2012US20120020969 Compositions And Methods For Inhibiting Viral Adhesion
01/26/2012US20120020964 Antibodies for Norovirus
01/26/2012US20120020960 Thymic Stromal Lymphopoietin (TSLP) and OX40 Ligand in Cancer
01/26/2012US20120020958 Fibcd1 for the prevention and treatment of diseases
01/26/2012US20120020957 Dengue virus neutralizing antibodies and use thereof
01/26/2012US20120020956 Activation of sodium potassium atpase
01/26/2012US20120020952 Methods for producing mixtures of antibodies
01/26/2012US20120020916 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
01/26/2012US20120020890 Staphylococcus aureus proteins and nucleic acids
01/26/2012US20120020888 Biomarker
01/26/2012CA2806921A1 Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
01/26/2012CA2806250A1 Cross-protective pathogen protection, methods and compositions thereof
01/26/2012CA2806166A1 Intracellular immunity
01/26/2012CA2806076A1 Anti-tumor antigen antibodies and methods of use
01/26/2012CA2805994A1 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile
01/26/2012CA2805985A1 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
01/26/2012CA2805978A1 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
01/26/2012CA2805963A1 A method of treating attention deficit hyperactivity disorder
01/26/2012CA2805961A1 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
01/26/2012CA2805943A1 A method of treating alzheimer's disease
01/26/2012CA2805794A1 Signal biomarkers
01/26/2012CA2805653A1 Anti-il-23 heterodimer specific antibodies
01/26/2012CA2805035A1 Novel antigen binding proteins
01/25/2012EP2410050A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody
01/25/2012EP2409993A1 Anti-CD19 antibody having ADCC function with improved glycosylation profile
01/25/2012EP2409992A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof
01/25/2012EP2409991A1 Antibody constant region variant
01/25/2012EP2409990A1 Antibody constant region variant
01/25/2012EP2409989A1 Method to improve glycosylation profile for antibody
01/25/2012EP2409712A1 Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile
01/25/2012EP2409711A1 Enzyme treatment of foodstuffs for celiac sprue
01/25/2012EP2409156A2 Akt tyrosine 176 phosphorylation cancer biomarker
01/25/2012EP2408934A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof
01/25/2012EP2408820A1 Humanised antibodies with anti-tumour activity
01/25/2012EP2408819A2 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof
01/25/2012EP2408818A1 Btla antibodies and uses thereof
01/25/2012EP2408817A1 Bispecific anti-her antibodies
01/25/2012EP2408816A2 Alpha-4-beta-7 heterodimer specific antagonist antibody
01/25/2012EP2408815A1 Reagents for the atherosclerotic coronary plaque and uses thereof
01/25/2012EP2408814A2 Carrier immunoglobulins and uses thereof
01/25/2012EP2408813A2 Optimized fc variants
01/25/2012EP2408812A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
01/25/2012EP2408804A1 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
01/25/2012EP2408476A2 Human immunodeficiency virus (hiv) -neutralizing antibodies
01/25/2012EP2408474A2 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
01/25/2012EP2408468A2 USE OF NKp46 FOR PREVENTING DIABETES
01/25/2012EP2069395B1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
01/25/2012EP2034017B1 Gene involved in immortalization of human cancer cell and use thereof
01/25/2012EP1613659B1 New monoclonal antibody capable of binding integrin alpha 10 beta 1
01/25/2012EP1545613B9 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
01/25/2012EP1532167B1 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
01/25/2012EP1432991B1 Identification and isolation of somatic stem cells and uses thereof
01/25/2012EP1412379B1 Vaccine
01/25/2012EP1355918B9 Recombinant protective protein from $i(streptococcus pneumoniae)
01/25/2012EP1351707B9 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
01/25/2012EP1192253B1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
01/25/2012EP1019437B1 Method for the covalent attachment of polysaccharides to protein molecules
01/25/2012CN1374870B Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody
01/25/2012CN102333872A Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
01/25/2012CN102333791A Generation, expression and characterization of the humanized k33n monoclonal antibody
01/25/2012CN102333790A An assay for detecting vitamin d and antibodies therefor
01/25/2012CN102333789A Anti-herpes simplex virus antibodies and methods of use thereof
01/25/2012CN102333542A Pcsk9拮抗剂 Pcsk9 antagonist
01/25/2012CN102333540A Compositions and methods related to bacterial eap, emp, and/or adsa proteins
01/25/2012CN102329781A Anti-human LIGHT monoclonal antibody and application thereof
01/25/2012CN102329394A Recombinant humanized anti-CD20 monoclonal antibody
01/25/2012CN102329393A Monoclonal antibody resisting Abeta (beta-amyloid) 42 peptide and application thereof
01/25/2012CN102329392A Specific anti-drug-resistant candida albicans hen egg yolk antibody IgY and preparation method and use thereof
01/25/2012CN102329391A Preparation method of monoclonal antibody for simultaneous detection of staphylococcal enterotoxins A and B
01/25/2012CN102329386A Achistosoma japonica Ago protein, gene, micro RNA (Ribonucleic Acid) and application thereof
01/25/2012CN102329385A Anti-apoptotic protein in schistosoma japonicum
01/25/2012CN102329378A HCV (hepatitis C virus) core antigen and antibody thereof as well as hybridoma cell lines secreting antibody
01/25/2012CN101717444B Kit for detecting melamine and application thereof
01/25/2012CN101709087B Puccinia triticina f.sp.tritic monoclonal antibody and application thereof
01/25/2012CN101550416B Humanized monoantibody Hu-ScFv18 light and heavy chain variable region gene and coding polypeptide thereof and application thereof
01/25/2012CN101014860B anti-robo1 antibody for preparing medicine for cancer diagnosis and treatment and related diagnosis kit
01/24/2012US8101728 TAB molecules
01/24/2012US8101727 Compositions and methods of use for antibodies of c-Met
01/24/2012US8101726 Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy
01/24/2012US8101725 Monoclonal antibodies to basic fibroblast growth factor
01/24/2012US8101724 High-affinity human antibodies to human protease-activated receptor-2
01/24/2012US8101723 Monoclonal antibodies to fibroblast growth factor receptor 2
01/24/2012US8101722 Bispecific binding molecule which interacts with CD3 complex which reduces immune response and decreases incidence of host vs graft diseases
01/24/2012US8101721 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
01/24/2012US8101720 Immunoglobulin insertions, deletions and substitutions
01/24/2012US8101719 Humanized anti-CD47 antibody
01/24/2012US8101713 Prostate cancer diagnosis and treatment
01/24/2012US8101712 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent
01/24/2012US8101553 Antibody library